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ICOS is required for the generation of both central and
effector CD4+ memory T-cell populations following
acute bacterial infection
Clare L. Marriott1, Gianluca Carlesso2, Ronald Herbst2
and David R. Withers1
1 Institute for Biomedical Research, College of Medical and Dental Sciences, University of
Birmingham, UK
2 Respiratory, Inflammation and Autoimmunity, Research Department, MedImmune LLC,
Gaithersburg, MD, USA
Interactions between ICOS and ICOS ligand (ICOSL) are essential for the development of
T follicular helper (Tfh) cells and thus the formation and maintenance of GC reactions.
Given the conflicting reports on the requirement of other CD4+ T-cell populations for ICOS
signals, we have employed a range of in vivo approaches to dissect requirements for ICOS
signals inmice during an endogenous CD4+ T-cell response and contrasted thiswith CD28
signals. Genetic absence of ICOSL only modestly reduced the total number of antigen-
specific CD4+ T cells at the peak of the primary response, but resulted in a severely
diminished number of both T central memory and T effector memory cells. Treatment
with blocking anti-ICOSmAb during the primary response recapitulated these effects and
caused amore substantial reduction than blocking CD28 signalswith CTLA4Ig. During the
memory phase of the response further signals through ICOS or CD28were not required for
survival. However, upon secondary challenge only Tfh cell expansion remained heavily
ICOS-dependent, while CD28 signals were required for optimal expansion of all subsets.
These data demonstrate the importance of ICOS signals specifically for memory CD4+
T-cell formation, while highlighting the potential of therapeutically targeting this path-
way.
Keywords: ICOS  CD28  CD4+ Memory  T-cell responses  Tfh
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Memory is a fundamental aspect of the adaptive immune response
that enables rapid responses against pathogens upon reencounter.
Memory T cells are the product of successful T-cell responses,
existing within long-lived populations that last many months in
mice [1] and years in humans [2]. T cells of any given specificity
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are rare [3], requiring extensive proliferation and differentiation
to form a pool of effector CD4+ T cells. The proliferation and dif-
ferentiation of naive CD4+ T cells requires both TCR/MHCII inter-
actions and costimulatory signals initially through CD28 [4, 5],
although subsequently many other receptor/ligand pairs can con-
tribute [6]. This results in effector T-cell subsets with distinct func-
tions and developmental requirements [7]. Evidence that memory
cells develop from effector cells, rather than as a separate pop-
ulation derives from observations that cytokine producing and
nonproducing effector cells generate memory cells equally well
[1, 8, 9]. The memory cell pool can be divided into two subsets
C© 2015 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co.
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based upon chemokine receptor expression and cytokine secre-
tion; T central memory (Tcm) cells express CCR7, required for
trafficking through secondary lymphoid tissue and need to pro-
liferate to produce cytokines other than IL-2. T effector memory
(Tem) cells lack CCR7 expression and thus are thought to be
unable to recirculate through secondary lymphoid tissue; rather
these cells can rapidly produce effector cytokines such as IFN-γ as
well as IL-2 upon antigen recognition [10, 11].
The signals that control the development and subsequent sur-
vival of the memory cell pool require further understanding. The
cytokines IL-7 and IL-15 are known to be important for the home-
ostasis of CD4+ memory T cells, while TCR/MHCII interactions are
not thought to be required [12]. Whether cell surface molecules
provide additional survival signals is unclear. Such experiments
are technically challenging since signals required for the formation
of the memory cell population must be distinguished from signals
required for persistence. Impaired CD4+ memory T-cell survival
in mice where group 3 innate lymphoid cells (ILC3s) were absent
suggests that costimulatory molecules expressed by these cells
such as OX40 ligand may support memory cells [13], however,
this has not been determined in vivo. Previous work indicated
that OX40 expression was tightly linked with antigen exposure
[14] rather than consistently expressed by memory CD4+ T cells,
suggesting other surfacemolecules may play a role in their survival
once formed.
CD28 family members regulate T-cell responses through cos-
timulatory and inhibitory signals [15, 16]. Previously, it has been
shown that CD28 and ICOS are essential for productive primary
CD4+ T-cell responses, however they each have distinct roles
[17, 18]. CD28 is constitutively expressed on CD4+ T cells and
is required to enhance T-cell proliferation and IL-2 production
[19, 20]. CD80−/−CD86−/− mice, which lack both ligands of CD28,
show impairments in isotype class switching and are unable to
form GC [21]. ICOS is upregulated on CD4+ T cells following
antigenic stimulation [17, 18, 22, 23] and engagement with ICOS
ligand (ICOSL) provides a key signal required for the generation
of T follicular helper cells (Tfh) and consequently the formation
and maintenance of GC [24, 25]. Thus deficiency in ICOS also
results in a reduction in class switched antibody and B-cell mem-
ory [22, 23, 26]. Studies in CD28-deficient mice demonstrated the
importance of ICOS signals to CD4+, but not CD8+ T-cell responses
to viral and parasite infections [27]. Recently the T cells of patients
with ICOS deficiency were characterized in detail and found to be
deficient in both Tcm and Tem cell populations, indicating that
ICOS signals are fundamental to the generation and/or the sur-
vival of these cells [28]. However, studies in mice have indicated
ICOS to be important specifically for the generation or survival
of Tem cells [29–31], although this relied heavily on identifying
Tem cells based only on CD44 and CD62L expression and the use
of unphysiological numbers of TCR transgenic T cells. A recent
study tracking endogenous antigen-specific CD4+ T cells revealed
a requirement for ICOS signals only in the Tcm population [11].
Therefore we sought to dissect the requirements of a poly-
clonal CD4+ T-cell population for CD28 and ICOS signals during
the different stages of a T-cell response. Using MHCII tetramers
an endogenous CD4+ T-cell population recognizing 2W1S peptide
was tracked, since such cells will most closely reflect the size and
polyclonality of the naive T cell pool in human patients. Our aim
was to determine at what points in a CD4+ T-cell response CD28
and ICOS signals were required, using a combination of block-
ing mAb and genetically deficient mice to enable WT memory
cells formed in vivo to be assessed. Genetic deficiency in ICOSL
or blockade of ICOS in the primary response resulted in a grossly
impaired memory cell pool with both Tcm and Tem cells reduced.
The subsequent survival of these cells did not require further sig-
nals through ICOS and only the Tfh cell population was dependent
on ICOS signals upon secondary challenge. While memory CD4+
T cells did not require further signals through CD28 for survival,
all subsets of T cells were at least partially dependent on CD28
signals for expansion upon secondary challenge. Collectively our
data indicate an essential role for ICOS in the formation of all
memory cells and highlight the potential of therapeutic targeting
of this pathway to block CD4+ T-cell responses.
Results
ICOS, as well as CD28, is required for optimal
formation of antigen-specific CD4+ T cells
To dissect the precise requirements for CD28 and ICOS signals dur-
ing a CD4+ T-cell response, we used the 2W1S model pioneered
by the Jenkins laboratory to enable an endogenous, polyclonal
population to be assessed. Mice were infected with an attenuated
Listeria monocytogenes expressing 2W1S peptide (Lm-2W1S) as
previously defined [1], and the 2W1S-specific CD4+ T-cell popu-
lation was tracked from primary proliferation through to resting
memory cells using MHCII tetramers. In this model, expression
of OX40 is closely linked to antigen exposure and tightly regu-
lated [14]. Na¨ıve CD44lo 2W1S-specific CD4+ T cells lacked ICOS
expression (Supporting Information Fig. 1), however, at all subse-
quent time points after activation (day 7, memory cells, 4 h post-
secondary challenge and day 3 post secondary challenge) ICOS
was expressed by all, or the majority of responding cells (Fig.
1A). Expression of ICOS was limited to CD44hi CD4+ T cells and
virtually absent in mice lacking the ligands of CD28 (Supporting
Information Fig. 1). Expression of ICOS on responding TCR trans-
genic CD4+ T cells was also assessed, using low numbers of SM1
T cells to model the population size of endogenous naive T-cell
pools [32]. ICOS expression was comparable with the endoge-
nous CD4+ T-cell population except on memory SM1 cells, which
expressed lower levels of ICOS than the memory 2W1S-specific
population (Fig. 1A). Following Lm-2W1S infection, three subsets
of CD4+ T cells can be defined: CXCR5−PD-1−T-bet+ effector cells
(Teff) that give rise to Tem cells, CXCR5+PD-1−Bcl-6+ central
memory precursors that give rise to Tcm cells and CXCR5+PD-
1+Bcl-6+ Tfh cells [11]. The Tcm precursor cell subset of 2W1S-
specific CD4+ T cells was significantly reduced in ICOSL−/− mice
7 dpi (days postinfection) with Lm-2W1S and Tfh cells were
almost absent (Fig. 1B and F), consistent with previous studies
C© 2015 The Authors. European Journal of Immunology published by
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Figure 1. ICOS, as well as CD28, is required
for optimal formation of antigen-specific
T cells in a primary response. WT mice were
infected with Lm-2W1S and 2W1S-specific
T cells were detected by flow cytometry. (A)
(top) Expression of ICOS on 2W1S:I-Ab+ CD4+
T cells and (bottom) TCR transgenic SM1 T cells
at 7 dpi, memory cells, 4 h and 3 (2W1S:I-Ab+)
or 4 (SM1) days postsecondary challenge. Plots
are gated on CD3+ B220−CD11b−CD11c− fol-
lowed by CD4+CD44hi T cells. (B–E) Enumera-
tion of CD44hi 2W1S:I-Ab+ CD4+ CXCR5− (Teff),
CXCR5+ (Tcm precursors), and CXCR5+PD−1+
(Tfh) cells 7 dpi in (B) ICOSL−/− mice; (C)
CD80−/−CD86−/− mice; (D) C57Bl/6 mice treated
with anti-ICOS or isotype control mAb 0 and
3 dpi; and (E) CTLA4Ig mice. (F and G) Expres-
sion pattern of CXCR5 and PD-1 by CD44hi
2W1S:I-Ab+ CD4+ T cells in (F) ICOSL−/− mice
and (G) CD80−/−CD86−/− mice. (A, F, and G) Plots
are representative of 6 mice from two inde-
pendent experiments in all experiments except
(A) ICOS expression on SM1 cells 7 dpi and
4 h post secondary challenge, which repre-
sent twomice. Values on plots are percentages.
(B–E) Graphs show pooled data from two inde-
pendent experiments, each data point repre-
sents one mouse. Bars show medians. Values
of 0 were assigned as 1. Mann–Whitney test: ns
p > 0.05, *p  0.05, **p  0.01, ***p  0.001.
of this response [1, 11]. CD80−/−CD86−/− mice were also ana-
lyzed 7 dpi as a comparison and all T-cell subsets were signifi-
cantly decreased in the absence of signaling through CD28 (Fig.
1C and G). We also sought to assess the effect of reagents blocking
these interactions to explore therapeutic targeting of these path-
ways within the context of this response. Blocking anti-ICOS mAb
were administered at 0 and 3 dpi before mice were analyzed 7 dpi
with Lm-2W1S. Notably, this mAb recapitulated the effects seen
in the ICOSL−/− mice, with Tfh cell formation most significantly
affected; although reductions in both the Tcm precursors and Teff
cell subsets were also observed (Fig. 1D). To assess blockade of
CD28 signals we investigated the 2W1S-specific response in mice
that express a CTLA4Ig fusion protein, blocking CD28 binding to
CD80 and CD86, analogous to abatacept therapy. Serum levels of
10–30 μg/mL CTLA4Ig are maintained in the CTLA4Ig mice [33].
Interestingly, while Tfh cell formation was substantially impaired,
consistent with an inability to form GC within these mice [33],
Teff and Tcm precursor populations were only modestly reduced
compared with the CD80−/−CD86−/− mice, consistent with an
incomplete block of available CD28 ligands (Fig. 1E). Support-
ing the partial blockade of CD28 signals in these mice, numbers
of Treg cells are substantially reduced in CTLA4Ig mice, com-
pared with WT controls, although not to the numbers detected in
CD80−/−CD86−/− mice (Supporting Information Fig. 2).
C© 2015 The Authors. European Journal of Immunology published by
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Figure 2. ICOS is required to form both Tcm
and Tem cell pools. (A–D) WT and ICOSL−/−
mice were infected with Lm-2W1S then restim-
ulated in vivo 28 dpi with 2W1S peptide. (A)
CD44hi 2W1S:I-Ab+ memory CD4+ T cells were
stained for cytokines IL-2 and IFN-γ and ana-
lyzed by flow cytometry. (B) Total number of
CD44hi 2W1S:I-Ab+ CD4+ T cells recovered at 7
and 28 dpi from WT and ICOSL−/− mice; bars
show median. (C) Fold difference between WT
and ICOSL−/− mice in number of CD44hi 2W1S:I-
Ab+ CD4+ T cells at 7 and 28 dpi. Bars show
mean + SEM of fold difference between exper-
iments. (D) CD44hi2W1S:I-Ab+ CD4+ memory
T cells with Tcm (IL-2+IFNγ−) or Tem (IL-
2+IFNγ+) phenotype were enumerated by flow
cytometry from WT and ICOSL−/− mice. Bars
showmean + SEM from 12mice. (E–G)WTmice
were infectedwith Lm-2W1S then restimulated
in vivo 28 dpi with 2W1S peptide after admin-
istration of anti-ICOS or isotype control mAb
at 0 and 4 dpi. (E) CD44hi2W1S:I-Ab+ memory
CD4+ T cells were stained for IL-2 and IFN-γ
and analyzed by flow cytometry. (F) Total
number of CD44hi 2W1S:I-Ab+ CD4+ memory
T cells recovered at 28 dpi; bars show medians.
(G) Tcm and Tem phenotype cells were enu-
merated by flow cytometry. Bars show mean +
SEM from 12mice. (H) WT and CD80−/−CD86−/−
mice were infected with Lm-2W1S then res-
timulated in vivo 28 dpi with 2W1S pep-
tide. (Left) Representative flow cytometry plots
and (right) total number of CD44hi 2W1S:I-
Ab+ CD4+ memory T cells recovered at 28
dpi. (A, E, and H) Plots are representative
of 6 mice from 2 independent experi-
ments, values on plots are percentages. (B–
D and F–H) Graphs show pooled data from
2 independent experiments. Each data point
represents one mouse. Mann–Whitney test:
*p  0.05, **p  0.01, ***p  0.001, ****p  0.0001.
ICOS is required for the formation of both Tcm and
Tem cells
Formation of a memory CD4+ T-cell pool is dependent upon
a robust primary response [32, 34]. Studies of ICOS−/− and
ICOSL−/− mice have concluded a specific loss of Tem cells [29, 30],
but following Lm-2W1S infection of chimeras reconstituted with
an equal mix of ICOS-deficient and WT bone marrow cells, a
reduced population of Tcm precursors was detected [11]. There-
fore we sought to assess the 2W1S-specific memory cell pool inWT
or ICOSL−/− mice 28 dpi with Lm-2W1S. To functionally identify
Tcm and Tem cells, mice were restimulated in vivo with 2W1S
peptide prior to analysis. Strikingly, the number of 2W1S-specific
memory cells was substantially reduced in ICOSL−/− mice (Fig. 2A
and B), with an approximate tenfold reduction in total number at
this time point, compared with an approximate 3.5-fold difference
at day 7 (Fig. 2C). Notably, both the Tcm and Tem populations
were heavily depleted compared with controls (Fig. 2D) in con-
trast to previous reports that observed effects only on the Tem
cells [11, 29, 30]. This impaired memory cell formation was also
seen when anti-ICOS mAb were administered to WT mice at 0
and 4 dpi (Fig. 2E–G). As expected, in CD80−/− CD86−/− mice,
the memory cell pool was barely detected (Fig. 2H). These data
indicate that signals through ICOS are essential in the formation
of a robust memory cell compartment despite modest effects on
total numbers of cells at the peak of the primary response.
CD28 and ICOS signals are not required for
antigen-specific memory T-cell survival
Whether memory CD4+ T cells require signals through ICOS and
CD28 for continued survival during the memory phase of the
response has not been robustly tested. To circumvent problems
associated with analyzing memory cell populations in mice where
priming may be impaired, WT mice were infected with Lm-2W1S
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 3. ICOS and CD28 costimulation are not required for antigen-
specific memory cell survival. (A) WT mice were infected with Lm-
2W1S, treated with blocking anti-ICOS or isotype control mAb twice
weekly for 4 weeks and 28 dpi CD44hi 2W1S:I-Ab+ CD4+ memory T cells
were enumerated by flow cytometry. (B–D) SM1 memory cells gener-
ated in WT mice were transferred into different hosts: (B) ICOSL−/−
mice; (C) CTLA4Ig mice; and (D) CD80−/−CD86−/− mice and the number
of surviving memory cells enumerated 4 weeks posttransfer by flow
cytometry. (A and D) Graphs show pooled data from two independent
experiments. (B, C) Graphs show representative data of two indepen-
dent experiments. Each data point represents one mouse; bars show
medians. Mann–Whitney test: ns p > 0.05.
and left for 4 weeks to form a 2W1S-specific memory popula-
tion. Blocking anti-ICOS or isotype control mAb were given at
28 dpi twice weekly for 4 weeks, then the memory cell population
was assessed. There was no significant difference in the number
of 2W1S-specificmemory cells recovered (Fig. 3A) indicating that
signals through ICOS were not required to maintain the memory
cell pool at this stage of the response. Since ICOS mAb blockade
may be incomplete, we sought a second method by which WT
memory cell survival could be assessed. Given the challenge of
transferring tetramer specific CD4+ T-cell populations, an allo-
type marked TCR transgenic SM1 memory population was gen-
erated in vivo by transferring 104 naive SM1 cells into WT hosts
that were then infected with attenuated Listeria monocytogenes
expressing Flic (Lm-Flic), thus keeping the agent with which the
mice were infected consistent. Through transferring low numbers
of TCR transgenic T cells, a physiological CD4+ T-cell response
is recapitulated [32]. After 4 weeks, the SM1 cells were enriched
and transferred into new hosts. Analysis of the memory SM1 cells
confirmed their expression of ICOS at this time (Fig. 1A). Approx-
imately 2.5 × 104 SM1 memory cells were transferred and mice
were analyzed 4 weeks posttransfer. Survival of WT SM1 mem-
ory cells was not impaired in ICOSL−/−, CD80−/−CD86−/−, or
CTLA4Ig mice indicating that signals through B7 costimulatory
molecules are not required for the continued survival of antigen-
specific memory cells once formed (Fig. 3B-D). Therefore while
formation of a robust memory population is highly dependent
upon both CD28 and ICOS, the persistence of these cells does not
require these signals.
ICOS is required for expansion of antigen-specific Tfh
cells post secondary challenge
Our data indicated that signals through ICOS were critical for the
generation of both Tcm and Tem populations, rather than the
subsequent survival of these cells during the memory phase of
the response. To assess the requirement for ICOS signals upon
secondary challenge mice were infected with Lm-2W1S and then
again at 28 dpi and analyzed 3 days later. Blocking anti-ICOS or
isotype control mAb were administered day 1 pre- and postsec-
ondary challenge. Mice receiving blocking anti-ICOS mAb showed
substantially impaired Tfh cell formation, modestly impaired Tem
populations and no significant effect on Tcm cells (Fig. 4A and
B). To further assess the contribution of costimulatory molecules
only at secondary challenge, SM1 memory cells generated in WT
mice were transferred into ICOSL−/− or WT hosts that were then
challenged 28 days later with Lm-Flic. While expansion of Tcm
and Tem cells was unaffected, again the number of number of
Tfh cells was substantially reduced indicating that this cell type
remains heavily ICOS dependent (Fig. 4C). In contrast, transfer
of SM1 memory cells into CD80−/−CD86−/− hosts subsequently
challenged with Lm-Flic revealed a significant reduction in all
of the T-cell subsets analyzed, demonstrating that these popula-
tions remain partially dependent on CD28 signals for expansion
(Fig. 4D).
Combination of CTLA4Ig and anti-ICOS mAb
enhances blockade of antigen-specific CD4+ T-cell
response
Antibody-mediated blockade of ICOS signals during the primary
response comprehensively blocked Tfh cell formation and signif-
icantly impacted on the resulting memory population, although
the total number of antigen-specific CD4+ T cells at day 7 was
only modestly reduced. Blocking anti-ICOS mAb caused a greater
reduction in the memory cell population at day 28 (approximate
tenfold reduction versus WT controls, Fig. 2B) than observed in
CTLA4Ig mice, where the fold difference was approximately 4
(Fig. 5A). Given the modest reduction in Teff and Tcm precur-
sors observed in the CTLA4Ig mice at day 7, we sought to assess
the effects of combined blockade of ICOS and CD28 signals as a
dual therapeutic approach. Therefore CTLA4Ig mice were treated
with blocking anti-ICOS or isotype control mAb at 0 and 3 dpi
with Lm-2W1S. At 7 dpi there was a reduction in all 2W1S-
specific T-cell subsets in CTLA4Ig mice that received blocking
anti-ICOS treatment compared to control treated CTLA4Ig mice
and Tfh cells were absent (Fig. 5B and C). Interestingly, there
was an approximate 8.5-fold reduction in 2W1S-specific CD4+
T cellsin CTLA4Ig mice treated with anti-ICOS mAb compared to
a 3.5-fold reduction inWTmice indicating that combined CTLA4Ig
and anti-ICOS treatment enhances blockade of the T-cell response
(Fig. 5D and E).
Finally, given that blockade of ICOS or CD28 signals alone
did not affect memory cell survival, we sought to test whether
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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this reflected redundancy in the requirement for these signals at
this time. Therefore, CTLA4Ig mice were infected with Lm-2W1S
and blocking anti ICOS or isotype control mAb were administered
for 4 weeks starting 28 dpi. Enumeration of 2W1S-specific CD4+
memory T cells revealed no significant difference, indicating that
rather than redundancy in the memory cell requirements for CD28
and ICOS signals, neither are necessary for survival at this stage
of the response (Fig. 5F).
Discussion
Studies on the importance of ICOS signals for CD4+ T-cell
responses have focused on the clear requirement for this molecule
in the formation of Tfh cells and T-dependent Ab responses
[24, 25, 31]. Here, we have dissected the different stages of a
CD4+ T-cell response and assessed the exact time at which ICOS
signals are required for the different subsets of an endogenous
CD4+ T-cell population. While CD28 signals were critical for the
early expansion of CD4+ T cells, the subsequent formation of a
robust memory cell pool was highly dependent on signals through
both CD28 and ICOS and mAb blocking ICOS during priming
effectively reduced memory cell numbers. Furthermore, we show
that in this systemic response, both the Tcm and Tem popula-
tions require ICOS for their generation, but not their subsequent
survival nor initial expansion upon secondary challenge.
Members of the TNF receptor super family such as OX40 have
been intensely studied as key signals in the survival of CD4+
T cells [35] and signals through these molecules are important in
the survival and function of Teff cells [36, 37]. While requirements
for costimulatory molecules likely depend upon the nature of the
infection and the type or quantity of antigen, a striking feature
of this study was the very brief expression of OX40 only at times
of antigen exposure [14]. In contrast, responding 2W1S-specific
CD4+ T cells retain expression of ICOS throughout the phases of
the response, an observation that prompted us to dissect when
signals though this molecule might be important. Several previ-
ous studies have indicated a requirement for ICOS only for CD4+
Tem cells and these have been reported to express the highest
levels of ICOS compared to Tcm and naive T cells [29]. Although
these studies have relied upon a surface phenotype, which does
not distinguish responding cells from memory phenotype cells
known to have different survival requirements [12], studies with
antigen-specific CD4+ T cells also indicated that only Tem cells
depend on ICOS for survival [30]. The data presented here clearly
show that in the response to Lm-2W1S infection, generation of
all memory cells was heavily dependent upon ICOS signals, which
is consistent with observations from human patients with ICOS

Figure 4. ICOS is required for expansion of antigen-specific Tfh cells
post secondary challenge. (A and B) WT mice were infected with Lm-
2W1S then challenged again at 28 dpi and treated with anti-ICOS or
isotype control mAb 1 day pre- and post secondary challenge with
Lm-2W1S. (A) Three days post secondary challenge CD44hi 2W1S:I-Ab+
CD4+ T cells were stained for CXCR5 and PD-1 expression and ana-
lyzed by flow cytometry. (B) CD44hi 2W1S:I-Ab+ CD4+ CXCR5− (Teff),
CXCR5+ (Tcm precursors), and CXCR5+PD-1+ (Tfh) cells were enumer-
ated 3 days post secondary challenge. (C and D) Mice were injected with
SM1 memory cells and challenged 28 days posttransfer. Enumeration
of SM1 memory cells that are CXCR5− (Teff), CXCR5+ (Tcm precursors),
and CXCR5+PD-1+ (Tfh) cells from (C) ICOSL−/− and (D) CD80−/−CD86−/−
mice day 4 post secondary challenge. (A) Plots are representative of 6
mice from two independent experiments. Values on plots are percent-
ages. (B, C) Graphs show pooled data or (D) representative data from
two independent experiments. Each data point represents one mouse;
bars show medians. Mann–Whitney test: ns p > 0.05, *p < 0.05, **p 
0.01, ***p  0.001.
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Figure 5. Therapeutic combination of blocking anti-ICOSmAb and CTLA4Ig enhances blockade of CD4+ T-cell response. (A) WT and CTLA4Ig mice
were infected with Lm-2W1S. CD44hi 2W1S:I-Ab+ CD4+ memory T cells were enumerated 28 dpi by flow cytometry. (B and C) CTLA4Ig mice were
infected with Lm-2W1S and treated with anti-ICOS or isotype control mAb 0 and 3 dpi. (B) CD44hi 2W1S:I-Ab+ CD4+ T cells were stained for CXCR5
and PD-1 expression 7 dpi and analyzed by flow cytometry. Plots are representative of 6 mice from three independent experiments. Values on
plots are percentages. (C) CD44hi2W1S:I-Ab+CD4+ CXCR5− (Teff), CXCR5+ (Tcm precursors), and CXCR5+PD−1+ (Tfh) cells were enumerated 7 dpi
from control and anti-ICOS treated mice. (D) CD44hi 2W1S:I-Ab+ CD4+ T cells were enumerated 7 dpi from WT and CTLA4Ig mice treated with
anti-ICOS or isotype control mAb 0 and 3 dpi. Kruskal–Wallis one-way ANOVA with post hoc Dunn’s test: *p  0.05. (E) Fold difference between
mice treated with anti-ICOS or isotype control mAb in number of CD44hi 2W1S:I-Ab+ CD4+ T cells in WT and CTLA4Ig mice. Bars show mean
+ SEM of fold difference between experiments. (F) CD44hi 2W1S:I-Ab+ CD4+ memory T cells were enumerated from CTLA4Ig mice 28 dpi with
Lm-2W1S, treatedwith blocking anti-ICOS or isotype controlmAb twice weekly for 4 weeks. (A, C–F) Graphs show pooled data from2 independent
experiments. Values of 0 were assigned as 1. Each data point represents one mouse; bars show medians. Mann–Whitney test: ns p > 0.05, **p 
0.01, ***p  0.001.
deficiency [28]. Interestingly, studies tracking HA-specific CD4+
memory cells using MHCII tetramers following i.n. infection with
influenza revealed no significant differences in the total memory
cell population in ICOS−/− mice, with a reduced Tem population
balanced by an expanded number of Tcm cells [30]. Furthermore,
Mahajan et al. concluded that following subcutaneous immuniza-
tion with H19-Env peptide emulsified with CFA, ICOS signals
were not required for memory cell survival, but were important
upon restimulation [26]. When compared with the data presented
here, these studies indicate that the importance of ICOS signals
in a CD4+ T-cell response may be dictated by the route of anti-
gen encounter, for example i.v. or i.n. infection with Lm-2W1S
results in very different memory cell responses [1]. Furthermore,
responses generated within mucosal secondary lymphoid tissue
may involve distinct costimulatory requirements, which should
be considered when immunizing at such sites or attempting to
block autoimmune T cells in such tissues. Different adjuvants or
types of infection will also likely shape the costimulatory pro-
file of the response, through the stimulation of distinct PRR. Our
experiments have focused on the response to Lm-2W1S and pre-
vious studies have identified an important role for ICOS signals in
the response to L. monocytogenes and other intracellular bacteria
[38, 39]. Finally, it is not clear whether the costimulatory require-
ments of memory cells upon secondary challenge depend upon the
nature of the initial response, which may explain the differences
between data presented here and in other studies [26].
Temporary blockade of ICOS during the primary response had
substantial effects on the resulting memory population, not dis-
similar to that observed in ICOSL−/− mice and more impressive
than in CTLA4Ig mice, demonstrating the therapeutic potential
of targeting this pathway to limit CD4+ T-cell responses. Since
both genetic deficiency in ICOSL or Ab-mediated blockade of ICOS
only modestly reduced the total number of antigen-specific CD4+
T cells at the peak of the primary response, this would indicate
that either signals through ICOS are required beyond 7 dpi or the
absence of these signals during the primary response caused the
survival of the CD4+ T cells to be grossly impaired. Although
the blocking anti-ICOS mAb has a half-life of approximately
7–10 days in vivo (G. Carlesso, unpublished observation), sys-
tematic blockade of ICOS signals at different time points in the
C© 2015 The Authors. European Journal of Immunology published by
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response is really required to dissect this further. While CD28 sig-
nals are clearly crucial for the initiation of CD4+ T-cell responses
and lie upstream of ICOS expression [17], therapeutic targeting of
CD28 signals using abatacept has yieldedmixed results clinically in
blocking CD4+ T-cell responses. Abatacept treatment has shown
promise in autoimmune conditions such as rheumatoid arthritis
and type 1 diabetes, but not multiple sclerosis or ulcerative colitis
[40]. In transplantation a modified version of abatacept has been
used, named belatacept, which more effectively inhibited renal
transplant rejection [40–42]. Blockade of ICOS signals has also
been trialed clinically and been shown to prolong cardiac allo-
graft survival [43, 44]. To further enhance costimulatory block-
ade combined targeting of multiple pathways has been proposed
[40, 45] and inhibition of both the ICOS and CD40 ligand path-
ways resulted in allograft tolerance and prevented autoimmune
diabetes in NOD mice [46]. Here, we show that whilst CTLA4Ig
mice produce 10–30 μg/mL serum levels of CTLA4Ig protein [33]
and GC development is blocked, the effect on other T-cell subsets
was surprisingly modest compared to CD80−/−CD86−/− mice. Our
data show that while signals through CD28 are clearly critical in
the generation of CD4+ T-cell responses, CTLA4Ig at the levels
maintained in these mice does not seem to provide a robust block-
ade of CD80 and CD86. Strikingly, provision of only two doses of
anti-ICOS mAb was sufficient to substantially reduce the resulting
memory T-cell population, while modestly affecting the primary
response, recapitulating data from ICOSL−/− mice. The combined
use of CTLA4Ig and anti-ICOS mAb in our model was far supe-
rior in blocking primary CD4+ T-cell responses, suggesting this
dual targeting may have significantly enhanced clinical benefit in
treating autoimmunity and graft rejection.
Whilst the cytokines IL-7 and IL-15 have been demonstrated
to affect memory CD4+ T-cell survival, a role for costimulatory
molecules remains unclear. To test a possible contribution from
CD28 or ICOS signals we generated antigen-specificmemory CD4+
T cells in vivo within WT hosts and subsequently transferred these
into ICOSL−/− or CD80−/−CD86−/− mice. The lack of these ligands
had no significant effect on the number of memory CD4+ T cells
subsequently recovered indicating that neither CD28 nor ICOS
signals are required solely for memory cell survival within the
timescale of these studies. Interestingly, this memory cell transfer
model indicated that CD4+ memory T cells remain dependent
on CD28 signals for optimal expansion upon secondary challenge,
consistent with studies of memory cell recall using CTLA4Ig fusion
proteins [47]. ICOS signals remain important for the generation of
Tfh cells upon challenge but had no clear effect on the expansion of
Tem and Tcm cells at this time point. Themodest reduction in Tem
cells after challenge observed with 2W1S-specific CD4+ T cells
in ICOSL−/− mice was not observed with SM1 cells, potentially
reflecting differences between endogenous and TCR transgenic
T cell responses.
In summary, beyond the formation of Tfh cells, signals through
ICOS appear critical for the generation of a functional pool of
Tem and Tcm cells following acute bacterial infection. The effec-
tiveness of anti-ICOS blocking mAb in this response suggests that
therapeutic targeting of this pathway may substantially improve
clinical attempts to control CD4+ T cells, perhaps in combination
with blockade of CD28 signals.
Materials and methods
Mice
Mice used were BoyJ, C57BL/6 (obtained from Harlan or in
house), ICOSL−/−, CD80/86−/−, CTLA4Ig [33], Rag−/− SM1
(CD45.1+CD45.2+). Mice were only compared to those that had
been bred in the same facility. Animals were bred in accordance
with Home Office guidelines at the University of Birmingham,
Biomedical Services Unit.
Cell transfer
A total of 104 SM1 cells harvested from spleen and peripheral
lymph nodes of TCR transgenic Rag−/− SM1 mice were injected
i.v. into C57BL/6 or BoyJmice before i.v. infectionwith Lm-Flic the
following day [48]. Formemory cell transfers, secondary lymphoid
tissues were harvested 28 dpi and cells were enriched using MACS
columns and transferred i.v. into hosts [32]. Cells were transferred
into twice as many recipients as donors, typically approximately
2.5 × 104 memory SM1 cell were transferred.
Infection
Micewere infected i.v. with 107 ActA-deficient Lm-2W1S (kind gift
from Dr. Marc Jenkins) or Lm-Flic (kind gift from Dr. Sing Sing
Way) as described [1, 14]. Mice were challenged at 28 dpi or post
SM1 memory cell transfer and mice were sacrificed on day 3 or 4
post secondary challenge, respectively. For in vivo restimulation
of memory cells mice were injected i.v. with 100 μg 2W1S peptide
and 2.5 μg LPS 28 dpi and analyzed after 4 h.
Antibody injection
Blocking anti-ICOS and isotype control mAb were provided by
MedImmune [49, 50]. Mice were injected i.p. with 0.25 mg anti-
ICOS or isotype control mAb. Mice were injected 0 and 3 dpi for
primary responses, 0 and 4 dpi for memory responses and 1 day
pre- and post secondary challenge. To assess memory cell survival
mice were injected twice weekly for 4 weeks from 28 dpi.
Flow cytometry
CD44hi 2W1S:I-Ab+ CD4+ T cells were enumerated from spleen at
7 dpi and a pool of spleen and LN for all memory responses. Stain-
ing with PE conjugated 2W1S:I-Ab was carried out as described
previously [14]. For in vivo restimulation experiments 10 μg
brefeldin A was added. Cell surface staining was done at 4°C
C© 2015 The Authors. European Journal of Immunology published by
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for 30 min, except for CXCR5 that was stained for 1 h at room
temperature. Enrichment for 2W1S-specific memory T cells was
performed, as described previously, using anti PE MicroBeads
(Miltenyi Biotech) and MACS enrichment [51]. Samples were
run using a Fortessa X20 (BD Biosciences) and analyzed using
FlowJo software (Tree Star). For intracellular cytoplasmic stain-
ing, cells were fixed and permeabilized with Cytofix/Cytoperm
Plus (BD). Intracellular cytokines were stained with IL-2 488
and IFN-γ PECy7 (BD Biosciences). Ten microliters of Spherotech
Accucount blank particles was used to calculate cell frequency.
Statistics
Data were analyzed using GraphPad Prism (version 6.0e). Non-
parametric Mann–Whitney test was used to determine significance
which was set at p  0.05. Kruskal–Wallis one-way ANOVA was
used to compare multiple groups with post hoc Dunn’s test where
stated. Median values were calculated and used in all analyses
except where stated.
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